Pharmaceutical Policy Interventions in Greece and their Impact The causes of rising pharmaceutical expenditure in Greece are multiple and can be attributed to many factors like increasing prescription volume and the inability to control rising volume trends, a generalised failure in the monitoring …
Pharmaceutical Policy Interventions in Greece and their Impact
The causes of rising pharmaceutical expenditure in Greece are multiple and can be attributed to many factors like increasing prescription volume and the inability to control rising volume trends, a generalised failure in the monitoring and implementation of prescribing guidance, higher-than-average European prices of low cost generic products, and the introduction of novel medicines at high cost, among others. This has resulted in fixed pharmaceutical budgets being exceeded over time. While publicly funded pharmaceutical spending remains fixed at 1% of GDP, total pharmaceutical spending has climbed to 2.5% of GDP, with pharmaceutical manufacturers significant amounts and patient out-of-pocket expenses also rising.